Max
@MaxKrummel
Followers
3K
Following
272
Media
39
Statuses
262
Prof @ucsf @immunox, Immunologist,Immunotherapy pioneer,believer in the power of curiosity,striving to make sense of complicated things, typically enthusiastic.
San Francisco, CA
Joined August 2017
Interested in the evolution of how we share and curate our science? For those coming to CICON24, check out @beiyun_liu and this poster. For those not there, try this out, participate, enjoy helping science and your colleagues move forward:
0
8
14
RT @SanchoLab: 🙏RT.📅Abstract deadline DC2024 Barcelona 30th May.🚨 SUBMIT NOW 👇.🔬34 short talks + posters!!!.🔝🌍speak….
0
24
0
RT @MiriamMerad: Looking forward to welcoming everyone to beautiful Killarney for #KSMyeloidTargets24 with co-organizer @MaxKrummel, and di….
0
15
0
RT @SanchoLab: Please, RT!!! .🚨DC lovers #DC2024Barcelona🚨.📅Abstract deadline approaching: SUBMIT NOW!!!.👇.34 slots….
0
28
0
Come check it out next Monday!.
@biorxivpreprint @MaxKrummel @cshperspectives more info on our upcoming talks at NYU and Columbia 👇
0
0
5
RT @SolvingForSci: In the NYC/Philly area? Come learn about what's happening at @biorxivpreprint and SolvingFor! Join @MaxKrummel and @cshp….
0
1
0
Very excited about this. Richard and I have a chance to share some pretty cool options to unleash science. Come check it out and try it out. Feels more like what we all came into science for… and a good product of all your collective minds.
Curious about academic publishing's future? Looking for open-access alternatives? . Upcoming seminar at UPenn w/ @cshperspectives of @biorxivpreprint & @medrxivpreprint and @MaxKrummel from @SolvingForSci should be illuminating!💡. 🕤3/20 10:30-11:30AM.📍CRB, Austrian Auditorium
0
3
11
I tried this out last week. It already feels much better as a reviewer when you are writing directly to the author and towards genuinely improving the quality of the science. It also is cognitively easier (and faster) to do a better job. This is going to be good.
Immunologists, are you stuck in peer review purgatory? đź•™. Or perhaps you're closing out the year with a new preprint!. We've got the pilot for you! Sign up to share your preprint, and let's fix publishing together!.
0
3
19
RT @MiriamMerad: Hope you can join @MaxKrummel and I at the keystone meeting we have organized on Myeloid Targeting Strategies for Cancer T….
0
25
0
RT @immunox: We are grateful to @FounderyInc. for their generosity and support of four ImmunoX fellows and for leading the charge in develo….
0
1
0
RT @RayArja: Are so-called 'M2-like' CD206+ macrophages immunosuppressive? On the contrary, we find that they are critical for T cell media….
0
26
0
RT @SolvingForSci: ‼️🚨Kick off your weekend with an intro to a new, journal-free system for publishing—developed by and for scientists—that….
0
9
0
Ten years ago, Miranda Broz first described rare CD103+ intratumoral DC (now:TucDC1) and their role in driving T cell responses. Here, @RayArja in the lab found the ID/signature of also-rare T cells that have exceptional effector responses. Formative.
biorxiv.org
Antitumor immunity is driven by CD8 T cells, yet we lack signatures for the exceptional effectors in tumors, amongst the vast majority of CD8 T cells undergoing exhaustion. By leveraging the measur...
3
11
79
An anchoring aspect of this work is that tumors get their immune archetypes from one of the many normal functions of the immune system. Tumor immunity is no longer simply about 'immunity' v. tolerance. Join the team to build on this understanding, build it up, knock it down.
🎉Our Cancer immune archetype perspective is on @NatureRevCancer's July cover!. We're seeking a #postdoc to unravel the cellular networks and gene programs behind these archetypes. If you're fueled by passion for immunology and oncology 👉Please RT🙏
0
5
29
There are higher risks associated with development of new ideas. Foundery Immune Studios provides crucial preclinical infrastructure+capital to bolster confidence in the therapeutic potential of novel ideas and develop them into first-in-class drugs. I was happy to share the idea.
0
1
3
In my experience, the most revolutionary scientific concepts face a high degree of skepticism from the venture community as they are supported by a limited number of experiments. Trapped in the 'therapeutic valley of death,' these ideas typically lie fallow in academia. 1/2.
1
1
12
Our lab ( is hiring a bioinformatics-minded person for the Immune Archetypes project.See it here: or apply here: I'm so proud of our ambitious and professional crowd; join us in SF!
0
11
24
What a great thing for Seattle and the Allen Institute! We’ll miss Ananda in CA but we’re all also so happy for an awesome scientist, collaborator and person.
0
0
13
RT @jvincentchan: Passionate about driving scientific research and making an impact? We're hiring a Research Development Strategist & Grant….
0
3
0
RT @SolvingForSci: Join us! SolvingFor is open to new members!. Our first campaigns are launching, our new hire starts soon, and new member….
solvingfor.org
SolvingFor is so proud of—and thankful for—everything that our community has cultivated, workshopped, and spun up thus far; and we’re ready to open our doors to new members.
0
3
0